Ken Griffin (Citadel Advisors) add Bristol-Myers Squibb Company
Ken Griffin (Citadel Advisors) add $94.3M of disclosed value in Bristol-Myers Squibb Company.
Signal
Investor Move
Action
Add
Capital
$94.3M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.